Procedures & recovery · patient guide

Robotic Prostatectomy in China: Understanding Cancer Staging

Cancer staging is the step that tells the surgical team whether a radical prostatectomy is appropriate for your cancer, and what the operation needs to achieve. Before you plan robotic prostatectomy in China, ask how the team will confirm staging, review your pathology, and set cancer-control and functional priorities.

Go to the practical guidance ↓
Editorial illustration: Robotic Prostatectomy in China: Understanding Cancer Staging
Illustrative image; not a photograph of a named hospital or an identified patient.
In this guide

Why staging decides whether robotic prostatectomy is even offered

A radical prostatectomy removes the prostate for selected prostate cancers. Robotic instruments are controlled by the surgeon. The word 'selected' is doing the real work in that sentence: the operation is offered when the cancer is believed to be confined in a way that surgery can address, and when the patient's overall situation makes an operation a reasonable option. Staging is how the treating team builds that picture.

Staging is not a single test. It combines what is already known: the biopsy result and Gleason grade, the PSA history, the clinical examination, and any imaging that has been done. The team then decides whether more information is needed before recommending an operation. If staging suggests the cancer may already extend beyond the prostate, a different treatment route may be discussed instead, or surgery may be planned with a different intent and scope.

This is why an overseas patient cannot treat staging as paperwork that happens after booking. The stage shapes the operation, the consent discussion, and what the team tells you to expect. If you arrive in China with an incomplete staging picture, the first days of your visit may be spent on tests rather than on preparation for surgery, and the plan may change.

The practical question is not 'what is my stage' as a label. It is: does the team believe the cancer is confined, and what is that belief based on? Ask them to walk you through the evidence, not just the conclusion.

What the surgical team needs to see before it can assess you

A records-based review is only as good as the records provided. For prostate cancer, the core documents are the pathology report from the prostate biopsy, including the Gleason score and the number of positive cores, the PSA results over time, and any imaging reports such as MRI, bone scan, or PSMA PET if performed. Operative notes from any previous prostate surgery, and a current medication list, also matter.

Pathology deserves particular attention. The biopsy report is the foundation of the staging assessment, and if it is incomplete, ambiguous, or from a laboratory whose reporting format the receiving team cannot easily interpret, the team may ask for blocks or slides to be re-reviewed. This is a normal quality step, not an accusation about your home laboratory. Ask in advance whether the team wants the original slides sent, and how.

Imaging is the other common gap. If you had an MRI at home, the report alone may not be enough; the team may want the actual images on disc or through a link. Ask what format they accept and whether they need the images before your appointment or can review them on arrival.

Do not send passport numbers, payment details, or your entire medical archive in a first message. A short summary with the diagnosis, the main question, and the key reports is enough to start. The detailed record exchange comes after the team tells you what it needs.

  • Biopsy pathology report with Gleason score and core details
  • PSA results with dates, showing the trend over time
  • Imaging reports and, if requested, the actual images
  • Current medication list and relevant past surgical notes

Cancer control and functional priorities are a single conversation

Staging answers whether surgery is appropriate. It does not answer what kind of surgery, or what trade-offs the patient is willing to accept. Those are separate discussions, and they belong together with the staging review.

On the cancer-control side, ask how the team plans to remove the prostate and whether they intend to remove lymph nodes, and why. Ask what the pathology of the removed prostate will be checked for, and how that result could change the follow-up plan. Ask whether the surgical margins will be assessed and what a positive margin would mean for you.

On the functional side, ask about continence and sexual function. No surgeon can promise a specific outcome, and any estimate is an estimate for a population, not a guarantee for you. What you can ask is how the team approaches nerve preservation, what factors make that more or less feasible in your case, and what support is available afterwards.

These two conversations interact. A wider operation for more extensive disease may change what is possible functionally. A patient who prioritises one over the other needs to say so clearly, because the surgeon cannot guess. Write down your priorities before the consultation and bring them to the discussion.

Catheter care and the early days after surgery

After a radical prostatectomy, a urinary catheter is normally left in place for a period while the join between the bladder and the urethra heals. The length of that period is a clinical decision for the treating team, and it varies with the operation and the patient. Do not plan your trip around a number you read online; ask the team what they expect in your case and what would change it.

Ask who will teach you catheter care, how to manage the bag during the day and at night, what to do if it blocks or leaks, and who to contact if something seems wrong. Ask whether you will be shown how to remove it yourself or whether that happens at a clinic visit. Ask what warning signs should prompt you to seek care urgently rather than wait.

The early days also involve wound care, pain management, and a plan for preventing clots. Ask what medicines you will be given, whether any of your regular medicines need to be paused, and who will manage that decision. Do not change any prescribed medicine on your own.

If you are travelling from abroad, ask how follow-up will be arranged once you return home. The receiving clinician at home will make their own assessment; the goal is to hand over clear records and a clear plan, not to assume the original team is the only one who can help.

Pathology review after surgery and what it changes

The staging assessment before surgery is a prediction. The pathology report on the removed prostate is the more definitive picture, and it can change the plan. The report describes the final Gleason score, whether the cancer reached the surgical margins, whether it extended beyond the prostate capsule, and whether any lymph nodes removed during surgery contained cancer.

Ask in advance when this report is expected, who will explain it to you, and how the result could change the follow-up. If the findings are more extensive than expected, the team may discuss additional treatment such as radiotherapy or hormone therapy, sometimes after a period of monitoring. If the findings are favourable, the plan may be active surveillance of PSA instead.

This is also the point where a second opinion on the pathology can be useful, particularly if the result is borderline or if the recommended next step is significant. A pathology review is a records-based exercise; it does not require you to travel. Ask whether the team recommends one and what material they would need.

Do not treat the post-surgery pathology report as a formality. It is the document that most directly determines what happens next, and you should have a clear explanation of it in writing.

What to confirm before you commit to travelling

Once the staging picture is reasonably complete, the practical questions become administrative. Ask the hospital what its written plan includes and what it does not, and who the payee is for each part. Ask whether the quoted scope covers the operation, the hospital stay, the pathology, and the follow-up visits, and what would be added if the plan changes during your stay. Ask for this in writing rather than relying on a verbal summary.

Ask how the team reviews your cancer-control and functional priorities, and who will lead that discussion. Ask what catheter care instructions you will receive and in what language. Ask how the post-surgery pathology will be reviewed and communicated, and how follow-up will continue after you leave China.

Ask what would make the team decide that surgery is not the right route for you, and what alternatives they would discuss. This is not a hostile question; it is the question that tells you whether the assessment is genuinely individual.

An initial enquiry is free and does not require buying a proxy consultation. The hospital decides suitability, and a records-based review does not establish that you will be accepted for surgery. Start with a short summary of the diagnosis, the staging information you have, and your main question. From there, the team can tell you what records it needs and what the next step is.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. BAUS: Robotic-assisted radical prostatectomy

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.